nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—SLC22A7—Fluorouracil—stomach cancer	0.101	0.193	CbGbCtD
Theophylline—CYP1B1—Docetaxel—stomach cancer	0.0856	0.163	CbGbCtD
Theophylline—SLC22A7—Docetaxel—stomach cancer	0.0775	0.147	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—stomach cancer	0.0638	0.121	CbGbCtD
Theophylline—SLC22A7—Methotrexate—stomach cancer	0.0559	0.106	CbGbCtD
Theophylline—CYP2C9—Capecitabine—stomach cancer	0.0334	0.0636	CbGbCtD
Theophylline—CYP2C8—Fluorouracil—stomach cancer	0.0284	0.054	CbGbCtD
Theophylline—CYP1A2—Fluorouracil—stomach cancer	0.022	0.0418	CbGbCtD
Theophylline—CYP2C9—Fluorouracil—stomach cancer	0.0198	0.0377	CbGbCtD
Theophylline—CYP3A4—Irinotecan—stomach cancer	0.012	0.0228	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—stomach cancer	0.0103	0.0196	CbGbCtD
Theophylline—CYP3A4—Docetaxel—stomach cancer	0.0088	0.0167	CbGbCtD
Theophylline—CYP3A4—Doxorubicin—stomach cancer	0.00656	0.0125	CbGbCtD
Theophylline—HDAC2—Topotecan—Irinotecan—stomach cancer	0.00465	1	CbGdCrCtD
Theophylline—PDE5A—blood vessel—stomach cancer	0.00385	0.0365	CbGeAlD
Theophylline—PDE3B—hematopoietic system—stomach cancer	0.00326	0.031	CbGeAlD
Theophylline—Caffeine—PIK3CA—stomach cancer	0.00277	1	CrCbGaD
Theophylline—PDE3B—pancreas—stomach cancer	0.00266	0.0252	CbGeAlD
Theophylline—ADA—hematopoietic system—stomach cancer	0.00247	0.0235	CbGeAlD
Theophylline—ADORA2B—smooth muscle tissue—stomach cancer	0.00238	0.0226	CbGeAlD
Theophylline—ADORA2A—hematopoietic system—stomach cancer	0.00225	0.0214	CbGeAlD
Theophylline—PDE3B—bone marrow—stomach cancer	0.00209	0.0199	CbGeAlD
Theophylline—PDE5A—hematopoietic system—stomach cancer	0.00205	0.0194	CbGeAlD
Theophylline—PDE3A—hematopoietic system—stomach cancer	0.00199	0.0189	CbGeAlD
Theophylline—ADORA1—hematopoietic system—stomach cancer	0.00194	0.0184	CbGeAlD
Theophylline—HDAC2—hematopoietic system—stomach cancer	0.00192	0.0182	CbGeAlD
Theophylline—PDE3B—endocrine gland—stomach cancer	0.00188	0.0178	CbGeAlD
Theophylline—PDE5A—epithelium—stomach cancer	0.00187	0.0178	CbGeAlD
Theophylline—PDE5A—smooth muscle tissue—stomach cancer	0.0018	0.0171	CbGeAlD
Theophylline—PDE3A—smooth muscle tissue—stomach cancer	0.00176	0.0167	CbGeAlD
Theophylline—HDAC2—epithelium—stomach cancer	0.00175	0.0166	CbGeAlD
Theophylline—ADA—lymphoid tissue—stomach cancer	0.00174	0.0165	CbGeAlD
Theophylline—ADA—digestive system—stomach cancer	0.00172	0.0163	CbGeAlD
Theophylline—PDE3B—liver—stomach cancer	0.00169	0.016	CbGeAlD
Theophylline—HDAC2—smooth muscle tissue—stomach cancer	0.00169	0.016	CbGeAlD
Theophylline—ADA—bone marrow—stomach cancer	0.00159	0.015	CbGeAlD
Theophylline—ADORA2A—lymphoid tissue—stomach cancer	0.00158	0.015	CbGeAlD
Theophylline—HDAC2—pancreas—stomach cancer	0.00156	0.0148	CbGeAlD
Theophylline—SLC22A7—digestive system—stomach cancer	0.00155	0.0147	CbGeAlD
Theophylline—PDE4B—hematopoietic system—stomach cancer	0.00144	0.0136	CbGeAlD
Theophylline—PDE5A—digestive system—stomach cancer	0.00143	0.0135	CbGeAlD
Theophylline—ADA—endocrine gland—stomach cancer	0.00142	0.0135	CbGeAlD
Theophylline—PDE4D—liver—stomach cancer	0.00141	0.0134	CbGeAlD
Theophylline—HDAC2—lymphoid tissue—stomach cancer	0.00135	0.0128	CbGeAlD
Theophylline—HDAC2—digestive system—stomach cancer	0.00133	0.0127	CbGeAlD
Theophylline—PDE3B—lymph node—stomach cancer	0.0013	0.0123	CbGeAlD
Theophylline—ADORA2A—endocrine gland—stomach cancer	0.00129	0.0123	CbGeAlD
Theophylline—SLC22A7—endocrine gland—stomach cancer	0.00128	0.0122	CbGeAlD
Theophylline—CYP1B1—hematopoietic system—stomach cancer	0.00123	0.0117	CbGeAlD
Theophylline—HDAC2—bone marrow—stomach cancer	0.00123	0.0117	CbGeAlD
Theophylline—PDE5A—endocrine gland—stomach cancer	0.00118	0.0112	CbGeAlD
Theophylline—PDE4B—pancreas—stomach cancer	0.00117	0.0111	CbGeAlD
Theophylline—ADORA2A—liver—stomach cancer	0.00117	0.0111	CbGeAlD
Theophylline—SLC22A7—liver—stomach cancer	0.00116	0.011	CbGeAlD
Theophylline—PDE3A—endocrine gland—stomach cancer	0.00115	0.0109	CbGeAlD
Theophylline—ADORA1—endocrine gland—stomach cancer	0.00112	0.0106	CbGeAlD
Theophylline—HDAC2—endocrine gland—stomach cancer	0.0011	0.0105	CbGeAlD
Theophylline—CYP1B1—smooth muscle tissue—stomach cancer	0.00108	0.0103	CbGeAlD
Theophylline—PDE4D—lymph node—stomach cancer	0.00108	0.0103	CbGeAlD
Theophylline—PDE3A—liver—stomach cancer	0.00103	0.0098	CbGeAlD
Theophylline—PDE4B—lymphoid tissue—stomach cancer	0.00101	0.0096	CbGeAlD
Theophylline—HDAC2—liver—stomach cancer	0.000994	0.00944	CbGeAlD
Theophylline—ADA—lymph node—stomach cancer	0.000982	0.00932	CbGeAlD
Theophylline—PDE4A—lymph node—stomach cancer	0.000957	0.00909	CbGeAlD
Theophylline—CYP2C8—hematopoietic system—stomach cancer	0.000943	0.00895	CbGeAlD
Theophylline—PDE4B—bone marrow—stomach cancer	0.000921	0.00874	CbGeAlD
Theophylline—CYP1A2—hematopoietic system—stomach cancer	0.000883	0.00838	CbGeAlD
Theophylline—CYP1A1—hematopoietic system—stomach cancer	0.000871	0.00826	CbGeAlD
Theophylline—CYP1B1—lymphoid tissue—stomach cancer	0.000867	0.00823	CbGeAlD
Theophylline—CYP1B1—digestive system—stomach cancer	0.000856	0.00813	CbGeAlD
Theophylline—CYP2C9—hematopoietic system—stomach cancer	0.000838	0.00795	CbGeAlD
Theophylline—PDE4B—endocrine gland—stomach cancer	0.000826	0.00784	CbGeAlD
Theophylline—PDE5A—lymph node—stomach cancer	0.000814	0.00773	CbGeAlD
Theophylline—CYP1A1—epithelium—stomach cancer	0.000796	0.00755	CbGeAlD
Theophylline—CYP2E1—hematopoietic system—stomach cancer	0.000794	0.00754	CbGeAlD
Theophylline—PDE3A—lymph node—stomach cancer	0.000792	0.00752	CbGeAlD
Theophylline—ADORA1—lymph node—stomach cancer	0.000772	0.00732	CbGeAlD
Theophylline—Vomiting—Floxuridine—stomach cancer	0.000763	0.00532	CcSEcCtD
Theophylline—HDAC2—lymph node—stomach cancer	0.000762	0.00723	CbGeAlD
Theophylline—Irritability—Fluorouracil—stomach cancer	0.000761	0.0053	CcSEcCtD
Theophylline—Hypokalaemia—Irinotecan—stomach cancer	0.000757	0.00528	CcSEcCtD
Theophylline—Rash—Floxuridine—stomach cancer	0.000757	0.00527	CcSEcCtD
Theophylline—Dermatitis—Floxuridine—stomach cancer	0.000756	0.00527	CcSEcCtD
Theophylline—Headache—Floxuridine—stomach cancer	0.000752	0.00524	CcSEcCtD
Theophylline—PDE4B—liver—stomach cancer	0.000744	0.00707	CbGeAlD
Theophylline—Body temperature increased—Mitomycin—stomach cancer	0.000744	0.00519	CcSEcCtD
Theophylline—Ventricular arrhythmia—Epirubicin—stomach cancer	0.000722	0.00503	CcSEcCtD
Theophylline—Albuminuria—Epirubicin—stomach cancer	0.000716	0.00499	CcSEcCtD
Theophylline—Nausea—Floxuridine—stomach cancer	0.000713	0.00497	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—stomach cancer	0.000712	0.00496	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—stomach cancer	0.000712	0.00496	CcSEcCtD
Theophylline—CYP1B1—endocrine gland—stomach cancer	0.000708	0.00672	CbGeAlD
Theophylline—Ventricular arrhythmia—Doxorubicin—stomach cancer	0.000668	0.00466	CcSEcCtD
Theophylline—Phlebitis—Docetaxel—stomach cancer	0.000668	0.00465	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—stomach cancer	0.000662	0.00462	CcSEcCtD
Theophylline—Extravasation—Methotrexate—stomach cancer	0.000654	0.00456	CcSEcCtD
Theophylline—Phlebitis—Capecitabine—stomach cancer	0.000646	0.00451	CcSEcCtD
Theophylline—Diarrhoea—Mitomycin—stomach cancer	0.000644	0.00449	CcSEcCtD
Theophylline—CYP3A4—hematopoietic system—stomach cancer	0.000639	0.00606	CbGeAlD
Theophylline—CYP1B1—liver—stomach cancer	0.000638	0.00606	CbGeAlD
Theophylline—Polyuria—Capecitabine—stomach cancer	0.000634	0.00442	CcSEcCtD
Theophylline—CYP2D6—hematopoietic system—stomach cancer	0.000629	0.00597	CbGeAlD
Theophylline—Dizziness—Mitomycin—stomach cancer	0.000623	0.00434	CcSEcCtD
Theophylline—Hyperuricaemia—Methotrexate—stomach cancer	0.000616	0.00429	CcSEcCtD
Theophylline—CYP1A2—digestive system—stomach cancer	0.000614	0.00583	CbGeAlD
Theophylline—Extravasation—Epirubicin—stomach cancer	0.000612	0.00427	CcSEcCtD
Theophylline—Atrial fibrillation—Docetaxel—stomach cancer	0.000607	0.00423	CcSEcCtD
Theophylline—CYP1A1—digestive system—stomach cancer	0.000605	0.00575	CbGeAlD
Theophylline—Vomiting—Mitomycin—stomach cancer	0.000599	0.00417	CcSEcCtD
Theophylline—Rash—Mitomycin—stomach cancer	0.000594	0.00414	CcSEcCtD
Theophylline—Dermatitis—Mitomycin—stomach cancer	0.000593	0.00413	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—stomach cancer	0.000592	0.00412	CcSEcCtD
Theophylline—Dermatitis exfoliative—Capecitabine—stomach cancer	0.00059	0.00411	CcSEcCtD
Theophylline—Headache—Mitomycin—stomach cancer	0.00059	0.00411	CcSEcCtD
Theophylline—Atrial fibrillation—Capecitabine—stomach cancer	0.000588	0.0041	CcSEcCtD
Theophylline—CYP2C9—digestive system—stomach cancer	0.000583	0.00553	CbGeAlD
Theophylline—Blood uric acid increased—Methotrexate—stomach cancer	0.000581	0.00405	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—stomach cancer	0.000576	0.00402	CcSEcCtD
Theophylline—PDE4B—lymph node—stomach cancer	0.000571	0.00542	CbGeAlD
Theophylline—Extravasation—Doxorubicin—stomach cancer	0.000567	0.00395	CcSEcCtD
Theophylline—Nausea—Mitomycin—stomach cancer	0.000559	0.0039	CcSEcCtD
Theophylline—CYP2E1—lymphoid tissue—stomach cancer	0.000559	0.00531	CbGeAlD
Theophylline—CYP2E1—digestive system—stomach cancer	0.000552	0.00524	CbGeAlD
Theophylline—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.000547	0.00382	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—stomach cancer	0.000544	0.00379	CcSEcCtD
Theophylline—CYP2C8—endocrine gland—stomach cancer	0.000542	0.00514	CbGeAlD
Theophylline—Flushing—Irinotecan—stomach cancer	0.000534	0.00372	CcSEcCtD
Theophylline—Hyperuricaemia—Doxorubicin—stomach cancer	0.000533	0.00372	CcSEcCtD
Theophylline—Irritability—Capecitabine—stomach cancer	0.000531	0.00371	CcSEcCtD
Theophylline—Urinary retention—Capecitabine—stomach cancer	0.000529	0.00369	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—stomach cancer	0.000528	0.00368	CcSEcCtD
Theophylline—Abdominal pain upper—Docetaxel—stomach cancer	0.000525	0.00366	CcSEcCtD
Theophylline—Coma—Methotrexate—stomach cancer	0.000522	0.00364	CcSEcCtD
Theophylline—Arrhythmia—Irinotecan—stomach cancer	0.000514	0.00358	CcSEcCtD
Theophylline—Alopecia—Irinotecan—stomach cancer	0.000509	0.00355	CcSEcCtD
Theophylline—Abdominal pain upper—Capecitabine—stomach cancer	0.000509	0.00355	CcSEcCtD
Theophylline—CYP1A2—endocrine gland—stomach cancer	0.000507	0.00481	CbGeAlD
Theophylline—Hypokalaemia—Capecitabine—stomach cancer	0.000507	0.00353	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—stomach cancer	0.000504	0.00351	CcSEcCtD
Theophylline—CYP1A1—endocrine gland—stomach cancer	0.0005	0.00475	CbGeAlD
Theophylline—Arrhythmia—Fluorouracil—stomach cancer	0.000492	0.00343	CcSEcCtD
Theophylline—CYP1B1—lymph node—stomach cancer	0.000489	0.00464	CbGeAlD
Theophylline—Dermatitis contact—Doxorubicin—stomach cancer	0.000489	0.00341	CcSEcCtD
Theophylline—CYP2C8—liver—stomach cancer	0.000489	0.00464	CbGeAlD
Theophylline—Coma—Epirubicin—stomach cancer	0.000488	0.0034	CcSEcCtD
Theophylline—Alopecia—Fluorouracil—stomach cancer	0.000487	0.0034	CcSEcCtD
Theophylline—CYP2C9—endocrine gland—stomach cancer	0.000481	0.00457	CbGeAlD
Theophylline—Polyuria—Methotrexate—stomach cancer	0.000472	0.00329	CcSEcCtD
Theophylline—CYP1A2—liver—stomach cancer	0.000457	0.00434	CbGeAlD
Theophylline—CYP2E1—endocrine gland—stomach cancer	0.000456	0.00433	CbGeAlD
Theophylline—Coma—Doxorubicin—stomach cancer	0.000452	0.00315	CcSEcCtD
Theophylline—CYP1A1—liver—stomach cancer	0.000451	0.00428	CbGeAlD
Theophylline—Phlebitis—Epirubicin—stomach cancer	0.00045	0.00314	CcSEcCtD
Theophylline—CYP3A4—digestive system—stomach cancer	0.000444	0.00422	CbGeAlD
Theophylline—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000439	0.00306	CcSEcCtD
Theophylline—CYP2D6—digestive system—stomach cancer	0.000437	0.00415	CbGeAlD
Theophylline—Hyperglycaemia—Capecitabine—stomach cancer	0.000434	0.00303	CcSEcCtD
Theophylline—CYP2C9—liver—stomach cancer	0.000434	0.00412	CbGeAlD
Theophylline—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000428	0.00299	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—stomach cancer	0.000417	0.0029	CcSEcCtD
Theophylline—Convulsion—Fluorouracil—stomach cancer	0.000416	0.0029	CcSEcCtD
Theophylline—CYP2E1—liver—stomach cancer	0.000411	0.0039	CbGeAlD
Theophylline—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000411	0.00287	CcSEcCtD
Theophylline—Haematuria—Capecitabine—stomach cancer	0.000409	0.00285	CcSEcCtD
Theophylline—Anaphylactic shock—Irinotecan—stomach cancer	0.000409	0.00285	CcSEcCtD
Theophylline—Infection—Irinotecan—stomach cancer	0.000406	0.00283	CcSEcCtD
Theophylline—Shock—Irinotecan—stomach cancer	0.000402	0.0028	CcSEcCtD
Theophylline—Nervous system disorder—Irinotecan—stomach cancer	0.000401	0.0028	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000401	0.00279	CcSEcCtD
Theophylline—Irritability—Methotrexate—stomach cancer	0.000396	0.00276	CcSEcCtD
Theophylline—Anaphylactic shock—Fluorouracil—stomach cancer	0.000392	0.00273	CcSEcCtD
Theophylline—Anorexia—Irinotecan—stomach cancer	0.00039	0.00272	CcSEcCtD
Theophylline—Infection—Fluorouracil—stomach cancer	0.000389	0.00271	CcSEcCtD
Theophylline—Nervous system disorder—Fluorouracil—stomach cancer	0.000384	0.00268	CcSEcCtD
Theophylline—Tachycardia—Fluorouracil—stomach cancer	0.000382	0.00266	CcSEcCtD
Theophylline—Hypotension—Irinotecan—stomach cancer	0.000382	0.00266	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.00038	0.00265	CcSEcCtD
Theophylline—Anorexia—Fluorouracil—stomach cancer	0.000373	0.0026	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000371	0.00259	CcSEcCtD
Theophylline—Insomnia—Irinotecan—stomach cancer	0.00037	0.00258	CcSEcCtD
Theophylline—Flushing—Docetaxel—stomach cancer	0.000369	0.00257	CcSEcCtD
Theophylline—CYP3A4—endocrine gland—stomach cancer	0.000367	0.00348	CbGeAlD
Theophylline—Hypotension—Fluorouracil—stomach cancer	0.000366	0.00255	CcSEcCtD
Theophylline—CYP2D6—endocrine gland—stomach cancer	0.000361	0.00343	CbGeAlD
Theophylline—Flushing—Capecitabine—stomach cancer	0.000358	0.00249	CcSEcCtD
Theophylline—Decreased appetite—Irinotecan—stomach cancer	0.000355	0.00248	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—stomach cancer	0.000355	0.00248	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—stomach cancer	0.000354	0.00247	CcSEcCtD
Theophylline—Insomnia—Fluorouracil—stomach cancer	0.000354	0.00247	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—stomach cancer	0.000353	0.00246	CcSEcCtD
Theophylline—Alopecia—Docetaxel—stomach cancer	0.000352	0.00245	CcSEcCtD
Theophylline—CYP1A1—lymph node—stomach cancer	0.000346	0.00328	CbGeAlD
Theophylline—Arrhythmia—Capecitabine—stomach cancer	0.000344	0.0024	CcSEcCtD
Theophylline—Decreased appetite—Fluorouracil—stomach cancer	0.00034	0.00237	CcSEcCtD
Theophylline—Alopecia—Capecitabine—stomach cancer	0.00034	0.00237	CcSEcCtD
Theophylline—Gastrointestinal pain—Irinotecan—stomach cancer	0.000334	0.00233	CcSEcCtD
Theophylline—CYP3A4—liver—stomach cancer	0.000331	0.00314	CbGeAlD
Theophylline—Abdominal pain upper—Doxorubicin—stomach cancer	0.000328	0.00229	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—stomach cancer	0.000327	0.00228	CcSEcCtD
Theophylline—CYP2D6—liver—stomach cancer	0.000326	0.00309	CbGeAlD
Theophylline—Abdominal pain—Irinotecan—stomach cancer	0.000323	0.00225	CcSEcCtD
Theophylline—Body temperature increased—Irinotecan—stomach cancer	0.000323	0.00225	CcSEcCtD
Theophylline—Tremor—Capecitabine—stomach cancer	0.000314	0.00219	CcSEcCtD
Theophylline—Urticaria—Fluorouracil—stomach cancer	0.000311	0.00217	CcSEcCtD
Theophylline—Body temperature increased—Fluorouracil—stomach cancer	0.00031	0.00216	CcSEcCtD
Theophylline—Palpitations—Docetaxel—stomach cancer	0.000306	0.00213	CcSEcCtD
Theophylline—Haematuria—Methotrexate—stomach cancer	0.000305	0.00212	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—stomach cancer	0.000302	0.00211	CcSEcCtD
Theophylline—Hypersensitivity—Irinotecan—stomach cancer	0.000301	0.0021	CcSEcCtD
Theophylline—Convulsion—Docetaxel—stomach cancer	0.0003	0.00209	CcSEcCtD
Theophylline—Palpitations—Capecitabine—stomach cancer	0.000296	0.00207	CcSEcCtD
Theophylline—Hypersensitivity—Fluorouracil—stomach cancer	0.000289	0.00201	CcSEcCtD
Theophylline—Haematuria—Epirubicin—stomach cancer	0.000285	0.00199	CcSEcCtD
Theophylline—Anxiety—Capecitabine—stomach cancer	0.000284	0.00198	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—stomach cancer	0.000283	0.00197	CcSEcCtD
Theophylline—Infection—Docetaxel—stomach cancer	0.000281	0.00196	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—stomach cancer	0.00028	0.00195	CcSEcCtD
Theophylline—Diarrhoea—Irinotecan—stomach cancer	0.00028	0.00195	CcSEcCtD
Theophylline—Shock—Docetaxel—stomach cancer	0.000278	0.00194	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—stomach cancer	0.000277	0.00193	CcSEcCtD
Theophylline—Pruritus—Fluorouracil—stomach cancer	0.000277	0.00193	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—stomach cancer	0.000276	0.00192	CcSEcCtD
Theophylline—Infection—Capecitabine—stomach cancer	0.000272	0.0019	CcSEcCtD
Theophylline—Dizziness—Irinotecan—stomach cancer	0.00027	0.00189	CcSEcCtD
Theophylline—Anorexia—Docetaxel—stomach cancer	0.000269	0.00188	CcSEcCtD
Theophylline—Shock—Capecitabine—stomach cancer	0.000269	0.00188	CcSEcCtD
Theophylline—Nervous system disorder—Capecitabine—stomach cancer	0.000268	0.00187	CcSEcCtD
Theophylline—Diarrhoea—Fluorouracil—stomach cancer	0.000268	0.00187	CcSEcCtD
Theophylline—Tachycardia—Capecitabine—stomach cancer	0.000267	0.00186	CcSEcCtD
Theophylline—Hypotension—Docetaxel—stomach cancer	0.000264	0.00184	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—stomach cancer	0.000264	0.00184	CcSEcCtD
Theophylline—Anorexia—Capecitabine—stomach cancer	0.000261	0.00182	CcSEcCtD
Theophylline—Vomiting—Irinotecan—stomach cancer	0.00026	0.00181	CcSEcCtD
Theophylline—Dizziness—Fluorouracil—stomach cancer	0.000259	0.00181	CcSEcCtD
Theophylline—Rash—Irinotecan—stomach cancer	0.000258	0.0018	CcSEcCtD
Theophylline—Dermatitis—Irinotecan—stomach cancer	0.000258	0.0018	CcSEcCtD
Theophylline—Headache—Irinotecan—stomach cancer	0.000256	0.00179	CcSEcCtD
Theophylline—Hypotension—Capecitabine—stomach cancer	0.000256	0.00178	CcSEcCtD
Theophylline—Insomnia—Docetaxel—stomach cancer	0.000256	0.00178	CcSEcCtD
Theophylline—Alopecia—Methotrexate—stomach cancer	0.000253	0.00177	CcSEcCtD
Theophylline—Flushing—Epirubicin—stomach cancer	0.000249	0.00174	CcSEcCtD
Theophylline—Vomiting—Fluorouracil—stomach cancer	0.000249	0.00174	CcSEcCtD
Theophylline—Insomnia—Capecitabine—stomach cancer	0.000248	0.00173	CcSEcCtD
Theophylline—Rash—Fluorouracil—stomach cancer	0.000247	0.00172	CcSEcCtD
Theophylline—Dermatitis—Fluorouracil—stomach cancer	0.000247	0.00172	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—stomach cancer	0.000246	0.00171	CcSEcCtD
Theophylline—Headache—Fluorouracil—stomach cancer	0.000245	0.00171	CcSEcCtD
Theophylline—Nausea—Irinotecan—stomach cancer	0.000243	0.00169	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—stomach cancer	0.00024	0.00167	CcSEcCtD
Theophylline—Decreased appetite—Capecitabine—stomach cancer	0.000238	0.00166	CcSEcCtD
Theophylline—Alopecia—Epirubicin—stomach cancer	0.000237	0.00165	CcSEcCtD
Theophylline—Nausea—Fluorouracil—stomach cancer	0.000233	0.00162	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—stomach cancer	0.000231	0.00161	CcSEcCtD
Theophylline—Flushing—Doxorubicin—stomach cancer	0.00023	0.00161	CcSEcCtD
Theophylline—Tension—Epirubicin—stomach cancer	0.000229	0.0016	CcSEcCtD
Theophylline—Nervousness—Epirubicin—stomach cancer	0.000227	0.00158	CcSEcCtD
Theophylline—Gastrointestinal pain—Capecitabine—stomach cancer	0.000224	0.00156	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—stomach cancer	0.000223	0.00156	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—stomach cancer	0.000223	0.00156	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—stomach cancer	0.000222	0.00155	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—stomach cancer	0.000219	0.00153	CcSEcCtD
Theophylline—Urticaria—Capecitabine—stomach cancer	0.000217	0.00152	CcSEcCtD
Theophylline—Abdominal pain—Capecitabine—stomach cancer	0.000216	0.00151	CcSEcCtD
Theophylline—Body temperature increased—Capecitabine—stomach cancer	0.000216	0.00151	CcSEcCtD
Theophylline—Convulsion—Methotrexate—stomach cancer	0.000216	0.00151	CcSEcCtD
Theophylline—Agitation—Epirubicin—stomach cancer	0.000215	0.0015	CcSEcCtD
Theophylline—Tension—Doxorubicin—stomach cancer	0.000212	0.00148	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—stomach cancer	0.00021	0.00146	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—stomach cancer	0.000208	0.00145	CcSEcCtD
Theophylline—Palpitations—Epirubicin—stomach cancer	0.000206	0.00144	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—stomach cancer	0.000204	0.00142	CcSEcCtD
Theophylline—Convulsion—Epirubicin—stomach cancer	0.000202	0.00141	CcSEcCtD
Theophylline—Infection—Methotrexate—stomach cancer	0.000202	0.00141	CcSEcCtD
Theophylline—Hypersensitivity—Capecitabine—stomach cancer	0.000202	0.00141	CcSEcCtD
Theophylline—Pruritus—Docetaxel—stomach cancer	0.0002	0.00139	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—stomach cancer	0.0002	0.00139	CcSEcCtD
Theophylline—Agitation—Doxorubicin—stomach cancer	0.000199	0.00138	CcSEcCtD
Theophylline—Anxiety—Epirubicin—stomach cancer	0.000198	0.00138	CcSEcCtD
Theophylline—Anorexia—Methotrexate—stomach cancer	0.000194	0.00135	CcSEcCtD
Theophylline—Pruritus—Capecitabine—stomach cancer	0.000194	0.00135	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—stomach cancer	0.000193	0.00135	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—stomach cancer	0.000191	0.00133	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—stomach cancer	0.000191	0.00133	CcSEcCtD
Theophylline—Hypotension—Methotrexate—stomach cancer	0.00019	0.00133	CcSEcCtD
Theophylline—Infection—Epirubicin—stomach cancer	0.000189	0.00132	CcSEcCtD
Theophylline—Shock—Epirubicin—stomach cancer	0.000188	0.00131	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—stomach cancer	0.000187	0.00131	CcSEcCtD
Theophylline—Diarrhoea—Capecitabine—stomach cancer	0.000187	0.00131	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—stomach cancer	0.000187	0.0013	CcSEcCtD
Theophylline—Dizziness—Docetaxel—stomach cancer	0.000187	0.0013	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—stomach cancer	0.000186	0.0013	CcSEcCtD
Theophylline—Insomnia—Methotrexate—stomach cancer	0.000184	0.00128	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—stomach cancer	0.000183	0.00128	CcSEcCtD
Theophylline—Anorexia—Epirubicin—stomach cancer	0.000182	0.00127	CcSEcCtD
Theophylline—Dizziness—Capecitabine—stomach cancer	0.000181	0.00126	CcSEcCtD
Theophylline—Vomiting—Docetaxel—stomach cancer	0.00018	0.00125	CcSEcCtD
Theophylline—Rash—Docetaxel—stomach cancer	0.000178	0.00124	CcSEcCtD
Theophylline—Hypotension—Epirubicin—stomach cancer	0.000178	0.00124	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—stomach cancer	0.000178	0.00124	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—stomach cancer	0.000177	0.00123	CcSEcCtD
Theophylline—Headache—Docetaxel—stomach cancer	0.000177	0.00123	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—stomach cancer	0.000176	0.00123	CcSEcCtD
Theophylline—Infection—Doxorubicin—stomach cancer	0.000175	0.00122	CcSEcCtD
Theophylline—Vomiting—Capecitabine—stomach cancer	0.000174	0.00121	CcSEcCtD
Theophylline—Shock—Doxorubicin—stomach cancer	0.000174	0.00121	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—stomach cancer	0.000173	0.00121	CcSEcCtD
Theophylline—Rash—Capecitabine—stomach cancer	0.000173	0.0012	CcSEcCtD
Theophylline—Insomnia—Epirubicin—stomach cancer	0.000172	0.0012	CcSEcCtD
Theophylline—Dermatitis—Capecitabine—stomach cancer	0.000172	0.0012	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—stomach cancer	0.000172	0.0012	CcSEcCtD
Theophylline—Headache—Capecitabine—stomach cancer	0.000171	0.0012	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—stomach cancer	0.000168	0.00117	CcSEcCtD
Theophylline—Nausea—Docetaxel—stomach cancer	0.000168	0.00117	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—stomach cancer	0.000167	0.00116	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—stomach cancer	0.000166	0.00116	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—stomach cancer	0.000165	0.00115	CcSEcCtD
Theophylline—Nausea—Capecitabine—stomach cancer	0.000163	0.00113	CcSEcCtD
Theophylline—Urticaria—Methotrexate—stomach cancer	0.000162	0.00113	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—stomach cancer	0.000161	0.00112	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—stomach cancer	0.000161	0.00112	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—stomach cancer	0.00016	0.00111	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—stomach cancer	0.000156	0.00109	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—stomach cancer	0.000153	0.00107	CcSEcCtD
Theophylline—Urticaria—Epirubicin—stomach cancer	0.000151	0.00106	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—stomach cancer	0.000151	0.00105	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—stomach cancer	0.000151	0.00105	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—stomach cancer	0.00015	0.00105	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000144	0.00101	CcSEcCtD
Theophylline—Pruritus—Methotrexate—stomach cancer	0.000144	0.001	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—stomach cancer	0.00014	0.000979	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—stomach cancer	0.00014	0.000977	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—stomach cancer	0.000139	0.000972	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—stomach cancer	0.000139	0.000972	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—stomach cancer	0.000139	0.000972	CcSEcCtD
Theophylline—Pruritus—Epirubicin—stomach cancer	0.000135	0.00094	CcSEcCtD
Theophylline—Dizziness—Methotrexate—stomach cancer	0.000135	0.000939	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—stomach cancer	0.00013	0.000909	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—stomach cancer	0.00013	0.000906	CcSEcCtD
Theophylline—Vomiting—Methotrexate—stomach cancer	0.00013	0.000903	CcSEcCtD
Theophylline—Rash—Methotrexate—stomach cancer	0.000128	0.000896	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—stomach cancer	0.000128	0.000895	CcSEcCtD
Theophylline—Headache—Methotrexate—stomach cancer	0.000128	0.00089	CcSEcCtD
Theophylline—Dizziness—Epirubicin—stomach cancer	0.000126	0.000879	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—stomach cancer	0.000125	0.00087	CcSEcCtD
Theophylline—Vomiting—Epirubicin—stomach cancer	0.000121	0.000845	CcSEcCtD
Theophylline—Nausea—Methotrexate—stomach cancer	0.000121	0.000844	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—stomach cancer	0.000121	0.000841	CcSEcCtD
Theophylline—Rash—Epirubicin—stomach cancer	0.00012	0.000838	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—stomach cancer	0.00012	0.000837	CcSEcCtD
Theophylline—Headache—Epirubicin—stomach cancer	0.000119	0.000833	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—stomach cancer	0.000117	0.000813	CcSEcCtD
Theophylline—Nausea—Epirubicin—stomach cancer	0.000113	0.00079	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—stomach cancer	0.000112	0.000782	CcSEcCtD
Theophylline—Rash—Doxorubicin—stomach cancer	0.000111	0.000775	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—stomach cancer	0.000111	0.000775	CcSEcCtD
Theophylline—Headache—Doxorubicin—stomach cancer	0.000111	0.00077	CcSEcCtD
Theophylline—Nausea—Doxorubicin—stomach cancer	0.000105	0.000731	CcSEcCtD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.17e-06	3.74e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PPARG—stomach cancer	8.16e-06	3.74e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.14e-06	3.73e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MYC—stomach cancer	8.13e-06	3.73e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP2A6—stomach cancer	8.12e-06	3.72e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GSTP1—stomach cancer	8.09e-06	3.71e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALOX5—stomach cancer	8.07e-06	3.7e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—stomach cancer	8.05e-06	3.69e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MYC—stomach cancer	8e-06	3.67e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—HMOX1—stomach cancer	7.98e-06	3.66e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—STAT3—stomach cancer	7.97e-06	3.65e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKR1C3—stomach cancer	7.97e-06	3.65e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MAPK1—stomach cancer	7.96e-06	3.65e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EGFR—stomach cancer	7.95e-06	3.65e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—DPYD—stomach cancer	7.94e-06	3.64e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL8—stomach cancer	7.92e-06	3.63e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—PIK3CA—stomach cancer	7.91e-06	3.63e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKR1C3—stomach cancer	7.9e-06	3.62e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MAPK3—stomach cancer	7.83e-06	3.59e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MAPK1—stomach cancer	7.83e-06	3.59e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EGFR—stomach cancer	7.82e-06	3.59e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—stomach cancer	7.81e-06	3.58e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PIK3CA—stomach cancer	7.8e-06	3.58e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPP2R1A—stomach cancer	7.78e-06	3.57e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ERBB2—stomach cancer	7.77e-06	3.56e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO1—stomach cancer	7.77e-06	3.56e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—stomach cancer	7.75e-06	3.55e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—stomach cancer	7.75e-06	3.55e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1B—stomach cancer	7.74e-06	3.55e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMP—stomach cancer	7.73e-06	3.54e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—FADS1—stomach cancer	7.73e-06	3.54e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO1—stomach cancer	7.7e-06	3.53e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—stomach cancer	7.67e-06	3.52e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—stomach cancer	7.66e-06	3.51e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTP1—stomach cancer	7.63e-06	3.5e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK3—stomach cancer	7.61e-06	3.49e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—stomach cancer	7.61e-06	3.49e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—stomach cancer	7.58e-06	3.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.57e-06	3.47e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—stomach cancer	7.55e-06	3.46e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—HMOX1—stomach cancer	7.53e-06	3.45e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—TYMS—stomach cancer	7.53e-06	3.45e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—stomach cancer	7.51e-06	3.44e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MAPK1—stomach cancer	7.45e-06	3.41e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—stomach cancer	7.45e-06	3.41e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GSTM1—stomach cancer	7.44e-06	3.41e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—stomach cancer	7.41e-06	3.4e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—stomach cancer	7.39e-06	3.39e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—stomach cancer	7.38e-06	3.38e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—JUN—stomach cancer	7.37e-06	3.38e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL8—stomach cancer	7.37e-06	3.38e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—stomach cancer	7.34e-06	3.36e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK3—stomach cancer	7.33e-06	3.36e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—stomach cancer	7.32e-06	3.35e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK1—stomach cancer	7.25e-06	3.32e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—stomach cancer	7.24e-06	3.32e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK3—stomach cancer	7.24e-06	3.32e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SREBF2—stomach cancer	7.24e-06	3.32e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—stomach cancer	7.22e-06	3.31e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.2e-06	3.3e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1B—stomach cancer	7.19e-06	3.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—stomach cancer	7.18e-06	3.29e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—stomach cancer	7.17e-06	3.29e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—RORA—stomach cancer	7.15e-06	3.28e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1A—stomach cancer	7.14e-06	3.27e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPP2R1A—stomach cancer	7.13e-06	3.27e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—stomach cancer	7.13e-06	3.27e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—stomach cancer	7.12e-06	3.26e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—TYMS—stomach cancer	7.09e-06	3.25e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—stomach cancer	7.04e-06	3.23e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—stomach cancer	7.03e-06	3.22e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTT1—stomach cancer	7.02e-06	3.22e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—NOS3—stomach cancer	7.02e-06	3.22e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTM1—stomach cancer	7.01e-06	3.21e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—stomach cancer	7e-06	3.21e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTP1—stomach cancer	7e-06	3.21e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ERCC2—stomach cancer	6.99e-06	3.21e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK1—stomach cancer	6.97e-06	3.2e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—stomach cancer	6.97e-06	3.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK8—stomach cancer	6.97e-06	3.19e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2A6—stomach cancer	6.94e-06	3.18e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—stomach cancer	6.91e-06	3.17e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—stomach cancer	6.9e-06	3.16e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—HMOX1—stomach cancer	6.9e-06	3.16e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK1—stomach cancer	6.89e-06	3.16e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—stomach cancer	6.89e-06	3.16e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CD44—stomach cancer	6.89e-06	3.16e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—stomach cancer	6.89e-06	3.16e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—stomach cancer	6.86e-06	3.15e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—stomach cancer	6.85e-06	3.14e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—stomach cancer	6.84e-06	3.14e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CD44—stomach cancer	6.83e-06	3.13e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—stomach cancer	6.79e-06	3.11e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKR1C3—stomach cancer	6.75e-06	3.09e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALDOB—stomach cancer	6.7e-06	3.07e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—stomach cancer	6.68e-06	3.06e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—stomach cancer	6.66e-06	3.05e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—stomach cancer	6.64e-06	3.04e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1A—stomach cancer	6.64e-06	3.04e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.62e-06	3.04e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ERCC2—stomach cancer	6.59e-06	3.02e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—stomach cancer	6.59e-06	3.02e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—stomach cancer	6.59e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO1—stomach cancer	6.58e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—stomach cancer	6.57e-06	3.01e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—stomach cancer	6.57e-06	3.01e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—stomach cancer	6.51e-06	2.98e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TYMS—stomach cancer	6.5e-06	2.98e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK8—stomach cancer	6.48e-06	2.97e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.47e-06	2.97e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—stomach cancer	6.46e-06	2.96e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—stomach cancer	6.44e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—stomach cancer	6.43e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—stomach cancer	6.42e-06	2.94e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—stomach cancer	6.39e-06	2.93e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—stomach cancer	6.37e-06	2.92e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—stomach cancer	6.36e-06	2.91e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—stomach cancer	6.3e-06	2.89e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—stomach cancer	6.29e-06	2.88e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—stomach cancer	6.28e-06	2.88e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—stomach cancer	6.25e-06	2.87e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALOX5—stomach cancer	6.23e-06	2.85e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—stomach cancer	6.2e-06	2.84e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—DPYD—stomach cancer	6.13e-06	2.81e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—stomach cancer	6.11e-06	2.8e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—stomach cancer	6.09e-06	2.79e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—stomach cancer	6.08e-06	2.79e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CAV1—stomach cancer	6.06e-06	2.78e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—stomach cancer	6.05e-06	2.77e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOA1—stomach cancer	6.05e-06	2.77e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—stomach cancer	6.05e-06	2.77e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—stomach cancer	6.01e-06	2.76e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—stomach cancer	5.98e-06	2.74e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—stomach cancer	5.98e-06	2.74e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—stomach cancer	5.98e-06	2.74e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—stomach cancer	5.92e-06	2.72e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—stomach cancer	5.92e-06	2.71e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPP2R1A—stomach cancer	5.86e-06	2.68e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—stomach cancer	5.85e-06	2.68e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CD44—stomach cancer	5.83e-06	2.67e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—stomach cancer	5.82e-06	2.67e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.81e-06	2.66e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK1—stomach cancer	5.79e-06	2.66e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—stomach cancer	5.79e-06	2.65e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—stomach cancer	5.79e-06	2.65e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—stomach cancer	5.74e-06	2.63e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—stomach cancer	5.72e-06	2.62e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CAV1—stomach cancer	5.72e-06	2.62e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOA1—stomach cancer	5.7e-06	2.61e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—stomach cancer	5.69e-06	2.61e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—stomach cancer	5.68e-06	2.6e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HMOX1—stomach cancer	5.66e-06	2.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.66e-06	2.59e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—stomach cancer	5.66e-06	2.59e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HMOX1—stomach cancer	5.62e-06	2.57e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—stomach cancer	5.6e-06	2.57e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—stomach cancer	5.57e-06	2.55e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—stomach cancer	5.53e-06	2.54e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—stomach cancer	5.5e-06	2.52e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—stomach cancer	5.47e-06	2.51e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.46e-06	2.5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTT1—stomach cancer	5.42e-06	2.48e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK1—stomach cancer	5.39e-06	2.47e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—stomach cancer	5.38e-06	2.47e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—stomach cancer	5.36e-06	2.46e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.36e-06	2.45e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TYMS—stomach cancer	5.34e-06	2.45e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—stomach cancer	5.33e-06	2.44e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—stomach cancer	5.3e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TYMS—stomach cancer	5.29e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—stomach cancer	5.28e-06	2.42e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CAV1—stomach cancer	5.24e-06	2.4e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—stomach cancer	5.23e-06	2.4e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOA1—stomach cancer	5.23e-06	2.4e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.21e-06	2.39e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—stomach cancer	5.09e-06	2.33e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO1—stomach cancer	5.08e-06	2.33e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—stomach cancer	5.03e-06	2.3e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—stomach cancer	5.03e-06	2.3e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.01e-06	2.3e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—stomach cancer	4.96e-06	2.27e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.96e-06	2.27e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—stomach cancer	4.92e-06	2.26e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—stomach cancer	4.87e-06	2.23e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—stomach cancer	4.86e-06	2.23e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HMOX1—stomach cancer	4.8e-06	2.2e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—stomach cancer	4.79e-06	2.2e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—stomach cancer	4.67e-06	2.14e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—stomach cancer	4.67e-06	2.14e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—stomach cancer	4.65e-06	2.13e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—stomach cancer	4.62e-06	2.12e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—stomach cancer	4.61e-06	2.11e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NOS3—stomach cancer	4.59e-06	2.1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TYMS—stomach cancer	4.52e-06	2.07e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—stomach cancer	4.52e-06	2.07e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—stomach cancer	4.52e-06	2.07e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CD44—stomach cancer	4.5e-06	2.06e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—stomach cancer	4.47e-06	2.05e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—stomach cancer	4.45e-06	2.04e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—stomach cancer	4.32e-06	1.98e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NOS3—stomach cancer	4.32e-06	1.98e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CAV1—stomach cancer	4.3e-06	1.97e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOA1—stomach cancer	4.29e-06	1.97e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CAV1—stomach cancer	4.27e-06	1.96e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOA1—stomach cancer	4.26e-06	1.95e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—stomach cancer	4.2e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—stomach cancer	4.19e-06	1.92e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—stomach cancer	4.14e-06	1.9e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—stomach cancer	4.14e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.08e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NOS3—stomach cancer	3.96e-06	1.82e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—stomach cancer	3.95e-06	1.81e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—stomach cancer	3.95e-06	1.81e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—stomach cancer	3.95e-06	1.81e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.83e-06	1.75e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—stomach cancer	3.78e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—stomach cancer	3.76e-06	1.72e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—stomach cancer	3.75e-06	1.72e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HMOX1—stomach cancer	3.7e-06	1.7e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CAV1—stomach cancer	3.65e-06	1.67e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOA1—stomach cancer	3.64e-06	1.67e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—stomach cancer	3.62e-06	1.66e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMS—stomach cancer	3.49e-06	1.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.48e-06	1.6e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—stomach cancer	3.45e-06	1.58e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—stomach cancer	3.4e-06	1.56e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—stomach cancer	3.37e-06	1.55e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NOS3—stomach cancer	3.25e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—stomach cancer	3.24e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NOS3—stomach cancer	3.23e-06	1.48e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—stomach cancer	3.2e-06	1.47e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—stomach cancer	3.05e-06	1.4e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—stomach cancer	2.98e-06	1.36e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—stomach cancer	2.95e-06	1.35e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—stomach cancer	2.88e-06	1.32e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CAV1—stomach cancer	2.81e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOA1—stomach cancer	2.81e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NOS3—stomach cancer	2.76e-06	1.26e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—stomach cancer	2.58e-06	1.18e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—stomach cancer	2.52e-06	1.16e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—stomach cancer	2.47e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.43e-06	1.12e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.23e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—stomach cancer	2.22e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NOS3—stomach cancer	2.13e-06	9.75e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—stomach cancer	1.95e-06	8.92e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.83e-06	8.39e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.82e-06	8.32e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.55e-06	7.11e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.2e-06	5.49e-06	CbGpPWpGaD
